ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,119.73
1.10%
Dow Jones
38,653.15
1.12%
US Dollar vs MXN
17.01302
0.24%
Brent Oil
83.245
-0.46%
Bitcoin
61,631.68
4.25%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)

  7. ProQR Therapeutics NV (PRQR) Noticias

PRQR

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRQR
FechaHoraFuenteTítuloSímboloCompañía
15/02/202406:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
14/02/202405:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
14/09/202316:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
16/05/202306:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
25/04/202305:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
24/04/202315:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
29/03/202315:55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
29/03/202315:54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
29/03/202315:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
14/02/202309:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
10/11/202205:35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
09/11/202214:40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
11/08/202220:15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
11/08/202207:37TipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
05/08/202205:38TipRanksH.C. Wainwright Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
04/08/202217:35TipRanksChardan Capital Reaffirms Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
04/08/202216:25TipRanksJMP Securities Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
08/05/202221:35TipRanksProQR (PRQR) Gets a Hold Rating from Stifel NicolausNASDAQ:PRQRProQR Therapeutics NV
06/05/202206:46TipRanksChardan Capital Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
05/05/202223:55TipRanksJMP Securities Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202206:25TipRanksChardan Capital Remains a Buy on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
13/04/202223:25TipRanksJMP Securities Reiterates Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
09/02/202209:27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRQRProQR Therapeutics NV
04/02/202208:13Edgar (US Regulatory)Schedule 13gNASDAQ:PRQRProQR Therapeutics NV
19/01/202223:25TipRanksJMP Securities Keeps Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
16/12/202115:15TipRanksProQR (PRQR) Gets a Buy Rating from JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
09/09/202110:20Dow Jones NewsProQR Therapeutics Shares Rise 29% After Research Deal With LillyNASDAQ:PRQRProQR Therapeutics NV
26/03/202111:33TipRanksAnalyst Lights Up Over ProQR Blindness Trial ResultsNASDAQ:PRQRProQR Therapeutics NV
21/01/202109:34TipRanks2 “Strong Buy” Penny Stocks That Could See Outsized GainsNASDAQ:PRQRProQR Therapeutics NV
06/08/202015:34Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRQRProQR Therapeutics NV
 Showing the most relevant articles for your search:NASDAQ:PRQR

Su Consulta Reciente

USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
NYSE
MCD
McDonalds
NASDAQ
AMZN
Amazon.com
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados